Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis

被引：0
|
作者：
Xiaoyun Li
Qin Zeng
Fengjiao Xu
Yuying Jiang
Zhongmei Jiang
机构：
[1] Chun’an County Hospital of Traditional Chinese Medicine,Department of Pharmacy
[2] Sichuan University,Laboratory of Pharmacology, Department of Pharmacology, School of Pharmacy
来源：
Molecular Diversity | 2023年 / 27卷
关键词：
Immune checkpoint; PD-1/PD-L1 inhibitors; Monoclonal antibodies drugs; Binding mode analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1935 / 1955
页数：20
相关论文
共 50 条
  • [1] Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
    Li, Xiaoyun
    Zeng, Qin
    Xu, Fengjiao
    Jiang, Yuying
    Jiang, Zhongmei
    [J]. MOLECULAR DIVERSITY, 2023, 27 (04) : 1935 - 1955
  • [2] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
    Wang, Tianyu
    Wu, Xiaoxing
    Guo, Changying
    Zhang, Kuojun
    Xu, Jinyi
    Li, Zheng
    Jiang, Sheng
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1715 - 1730
  • [3] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu, Qiang
    Li, Chun-Sheng
    [J]. CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 986 - 992
  • [4] Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis
    Liu Qiang
    Li Chun-Sheng
    [J]. 中华医学杂志(英文版), 2017, (08) : 986 - 992
  • [5] Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold
    Qin, Mingze
    Cao, Qi
    Wu, Xia
    Liu, Chunyang
    Zheng, Shuaishuai
    Xie, Hongbo
    Tian, Ye
    Xie, Jun
    Zhao, Yanfang
    Hou, Yunlei
    Zhang, Xian
    Xu, Boxuan
    Zhang, Haotian
    Wang, Xiaobo
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 186
  • [6] SAR study of small molecule inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
    Kawashita, Seiji
    Aoyagi, Koichi
    Fukushima, Kyoko
    Hantani, Rie
    Naruoka, Shiori
    Tanimoto, Atsuo
    Hori, Yuji
    Toyonaga, Yukiyo
    Yamanaka, Hiroshi
    Miyazaki, Susumu
    Hantani, Yoshiji
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 98 (05) : 914 - 929
  • [7] Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis
    Zhang, Chen
    Yang, Qing
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
  • [8] Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
    Cheah, Chan Yoon
    Fowler, Nathan H.
    Neelapu, Sattva S.
    [J]. CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) : 384 - 391
  • [9] Discovery of phenyl-linked symmetric small molecules as inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
    Wu, Yizhe
    Zhang, Yu
    Guo, Yu
    Pan, Zhichao
    Zhong, Shichun
    Jin, Xinxin
    Zhuang, Weihao
    Chen, Sikang
    Gao, Jian
    Huang, Wenhai
    Dong, Xiaowu
    Che, Jinxin
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [10] Symmetry-based ligand design and evaluation of small molecule inhibitors of programmed cell death-1/programmed death-ligand 1 interaction
    Kawashita, Seiji
    Aoyagi, Koichi
    Yamanaka, Hiroshi
    Hantani, Rie
    Naruoka, Shiori
    Tanimoto, Atsuo
    Hori, Yuji
    Toyonaga, Yukiyo
    Fukushima, Kyoko
    Miyazaki, Susumu
    Hantani, Yoshiji
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (17) : 2464 - 2467
12345